Detalhe da pesquisa
1.
Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors.
Br J Cancer
; 124(7): 1249-1259, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33473169
2.
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.
Int J Mol Sci
; 22(8)2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917022
3.
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Int J Mol Sci
; 21(3)2020 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32024004
4.
HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer.
Invest New Drugs
; 37(3): 441-451, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30062574
5.
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
Mol Cancer
; 22(1): 175, 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37915024
6.
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells.
Invest New Drugs
; 36(4): 581-589, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396630
7.
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
BMC Cancer
; 18(1): 965, 2018 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305055
8.
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy.
Mol Cancer
; 13: 157, 2014 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24958351
9.
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors.
Life (Basel)
; 13(3)2023 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36983764
10.
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer.
PLoS One
; 18(3): e0282512, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920947
11.
FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures.
AAPS J
; 24(6): 108, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229752
12.
GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic TumorsCurrent Challenges and Future Directions
Cancers (Basel)
; 13(3)2021 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33514073
13.
Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer.
Ther Adv Med Oncol
; 12: 1758835919897546, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064003
14.
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer.
Cancers (Basel)
; 11(6)2019 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31141894
15.
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts.
Proteomes
; 6(4)2018 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30404163